European Journal of Molecular & Clinical Medicine

Abstract

The aim: of this study is to investigate the prevalence of anosmia and its impact on quality of life among COVID-19 positive patients. 
 
Objectives:
To confirm tthe high prevalence and severity of smell disorders among laboratory-confirmed SARS-CoV-2 patients.To assess the impact of anosmia on quality of life among covid patients. To evaluate anosmia features and duration.
 
Materials and Methods
 
Study Design: Cross-sectional study. Study population: Patients diagnosed with covid-19 in Hail city constitute the population of the study. Sample collection: pre-validated self-administered questionnaire. Sample collection and processing: pre-validated and translated self-administered electronic questionnaire. The sample size was calculated by using the Rao soft sample size calculator. We will be collecting a sample size of 137, with a confidence level of 95% and a margin of error of 5%.
Rationale:
The sudden onset of smell loss has been reported as a symptom related to COVID-19, the rationale of this study is to provide an insight into the prevalence of the olfactory disorder.
 
Results:
A total of 213 covid-19 patients complained of anosmia Between the ages of 18 and 60, with a mean age of 36.2 + 11.9 years. Covid-19 patients' anosmia and quality of life in Hail, Saudi Arabia.74.4 percent of patients who were not concerned about future changes in their sense of smell had an excellent quality of life, compared to 23.7 percent of those who were. This difference was statistically significant (P=.001).